Spinal manipulation reduces pain and improves function in chronic low back pain — and the January 2026 Cochrane update puts the limit up front: against other conservative care the difference in pain is negligible, and the certainty of the evidence is low to very low. PEMF, tested separately, reduced chronic low back pain across 14 trials. The two have never been tested together. Here is what the research supports, what it does not, and how the two fit into a single clinic visit.
August 2026 · 13 min read · Integrative Protocol
Spinal manipulative therapy (SMT) has a real but modest short-term effect on chronic low back pain — and the most authoritative source is candid about its own limits. The Cochrane review updated in January 2026 (76 RCTs, 11,866 participants; PubMed 41494147) reports three separate results that must not be blurred together: versus sham manipulation, a small pain reduction and a medium functional improvement at one month, at very low certainty; versus no treatment, a medium pain reduction (MD −13.99, 95% CI −27.33 to −0.66) and a large functional improvement (SMD −0.84); and versus other conservative interventions, little to no difference in pain (MD −4.72 on a 100-point scale, 31 studies, N=4,109) with a small functional gain (SMD −0.25). PEMF, tested separately, reduced chronic low back pain in a 14-trial meta-analysis (N=618, SMD −1.01, p<0.001). The two have never been tested together in a controlled trial — a PubMed cross of chiropractic or spinal manipulation with PEMF returns a single case report of one patient.
Chiropractic care centres on manipulation and mobilisation of the spinal joints. The signature technique is HVLA — High-Velocity Low-Amplitude — a short, fast thrust through a small range on a specific joint, often accompanied by an audible pop.
It is worth being precise about that sound. It is cavitation: the collapse of a gas bubble in the synovial fluid following a sudden pressure drop. It is not a vertebra returning to place. There is no evidence that manipulation moves a vertebra from or to an anatomical position, and the research supporting the technique does not claim that it does.
The accepted mechanism is neurophysiological rather than structural: the rapid stretch activates mechanoreceptors in the joint capsule and surrounding muscle, transiently reduces muscle tone and pain sensitivity, and widens the tolerated range of motion. Two practical consequences follow — the effect is real but short-lived, and its purpose is to open a window in which the patient can move and exercise.
A 2026 umbrella review with meta-analysis in Annals of Physical and Rehabilitation Medicine (21 systematic reviews, 35,711 participants; PubMed 41289922) reaches the same conclusion from another direction: manual therapy outperforms other interventions on pain (MD −10.52, 95% CI −13.71 to −7.33) and disability (SMD −0.60, 95% CI −0.80 to −0.40) in the short term only — and the effect diminishes over time.
That decay is the single most consistent finding in the entire manual-therapy literature, and it is precisely what should determine how the modality is used: as a window-opener for active rehabilitation, not as the treatment itself.
An international expert consensus published in Clinical Rehabilitation in 2024 (PubMed 38317586) recommends spinal manipulative therapy for acute low back pain, and core stability/motor control exercise, manipulation and massage for sub-acute low back pain.
The practical question is not "does chiropractic work" but "does it add anything on top of active exercise" — and here the answer splits in an instructive way. A 2026 meta-analysis in Musculoskeletal Science and Practice (5 RCTs, N=260; PubMed 41643247) tested exactly that: manual therapy added to exercise versus exercise alone.
A further systematic review of 10 studies (PubMed 40325660) found eight reporting improvement and two reporting no benefit at all.
And the central gap, which we state first: a PubMed cross of chiropractic or spinal manipulation with pulsed electromagnetic fields returns not a single controlled trial. The only record connecting the two is a single case report published in 2026 (one 66-year-old patient after lumbar fusion, in a multimodal programme of PEMF, shockwave and structural rehabilitation; PubMed 41694169). A case report of one patient is not evidence of efficacy, and it is presented here as such and not as support.
In most cases yes — but the precise answer depends on which question is being asked. A 2024 systematic review and meta-analysis of randomised trials in Pain Physician (14 studies; PubMed 38805524) found no statistically significant difference in adverse-event rates between cervical manipulation and control groups, and every adverse event reported was mild — muscle soreness, stiffness or a transient increase in pain. The 2026 Cochrane review reports the same picture for the low back: no serious complication across all 76 trials.
And immediately after it, the caveat the authors themselves stress: randomised trials are not the right instrument for detecting rare serious adverse events. The complication at issue — cervical artery dissection — is too rare to appear in samples of this size, and the evidence about it comes from case reports and case-control studies that cannot establish causation.
The practical clinic conclusion: cervical manipulation requires pre-screening — dizziness, double vision, speech or swallowing disturbance, a new and uncharacteristic head or neck pain, and any suspicion of neurological deficit. In each of these, do not manipulate; refer for investigation. This is also one reason a no-contact modality such as PEMF is sometimes used as a preceding or alternative component when the neck is irritable or the screen is not clear-cut.
Here the evidence base is narrower but more consistent. A meta-analysis in Clinical Rehabilitation (14 RCTs, N=618; PubMed 35077249) found PEMF reduced back pain more than placebo (SMD −1.01, 95% CI −1.42 to −0.6, p<0.001, I²=31%), with a significant effect in chronic back pain (SMD −0.6, p<0.001) — but no significance in acute back pain (p=0.09) and no significant improvement in physical function (p=0.09). The 2025 multi-centre trial in joint and soft-tissue pain (N=91, 5 orthopaedic clinics; PMC11914662) showed a 36% pain reduction versus 10% with standard care (p<0.0001) and a 55% drop in medication use.
In the cervical spine, two parallel randomised trials of PEMF in knee (N=86) and cervical spine (N=81) osteoarthritis across 18 half-hour sessions (PubMed 7837158) found statistically significant improvement in pain and function versus placebo, sustained at one-month follow-up. Note the structural difference from manual therapy: this is a series of 18 sessions rather than a single act — dose accumulation is part of the mechanism, not a side effect of it.
The rationale is a division of labour by duration of effect and type of stimulus. This division rests on mechanism, not on direct research.
Manipulation acts mechanically, locally and immediately: a short thrust on a specific joint activates stretch receptors, reduces muscle tone and widens range within seconds — then decays. Pulsed electromagnetic fields act volumetrically and cumulatively: a changing magnetic field induces a micro-current in the tissue, influences cell membrane potential, and modulates oedema, local inflammation and microcirculation throughout the tissue volume within the field — through clothing, without contact and without heating. Put simply: the adjustment opens movement in a moment; the magnetic field works on the tissue across the series.
An operational advantage follows directly from the mechanism: manipulation takes a few minutes and requires the clinician present throughout, whereas PEMF requires no contact at all — so it can be applied immediately after the adjustment, on the same region, without adding mechanical stimulus to already-irritated tissue.
Spinal manipulation: advanced osteoporosis, suspected fracture or spinal metastases, infection, progressive or evolving neurological deficit, significant anticoagulant therapy, and any suspicion of cervical artery dissection.
PEMF: a pacemaker, defibrillator or active electronic implant, pregnancy, active epilepsy, and active malignancy.
Note that these lists barely overlap — which is precisely why a patient who cannot be manipulated can often still be treated, and vice versa.
| Parameter | Chiropractic | Osteopathy | Physiotherapy | PEMF |
|---|---|---|---|---|
| Principle of action | HVLA manipulation of spinal joints | Varied manual techniques, including soft tissue and fascia | Structured active exercise, plus manual technique | Pulsed magnetic field penetrating the tissue volume |
| Duration of effect | Immediate and short-term, decays over time | Short-term | Cumulative, the longest lasting | Cumulative across the series |
| Contact and invasiveness | Direct manual contact, no tissue penetration | Direct manual contact | Partial contact, mainly guidance | No contact at all, works through clothing |
| Depth of evidence base | 76 RCTs, N=11,866 (Cochrane 2026) — low to very low certainty | Included in the umbrella review: 21 reviews, N=35,711, short-term effect | The strongest base for long-term change | 14 RCTs, N=618 (back); multi-centre trial N=91 |
| Clinician time in clinic | Active presence required throughout | Active presence required throughout | Active presence required | Hands-free — the device runs on its own |
Three categories should not be confused: a clinical PEMF system operated in a clinic after diagnosis; a medical-grade home PEMF device, which PainFree rents or sells to patients for home rehabilitation; and consumer wellness products (mats and mattresses), which are not medical equipment and carry no defined indication.
The clinical system has the highest field intensity, the full coil range and an indication-specific protocol library. The medical-grade home device is more powerful than the common consumer home devices and less powerful than the clinical system — its advantage is frequency: daily, even twice daily use, versus 1–2 sessions a week in clinic. For a symptom that follows a daily cycle, cumulative dose is the real difference between the two routes. Manipulation itself is performed in clinic only; the home device is used between sessions to hold the gain.
The technological contrast with consumer gadgets is physics rather than marketing: infrared and laser light are absorbed in the superficial layers of skin, while a magnetic field passes through tissue and bone without significant absorption. PEMF devices with FDA 510(k) clearance for pain and oedema exist on the market, as do devices carrying CE marking. Regulatory clearance always applies to a specific device model and has an expiry date — ask to see the current certificate for the model offered to you.
Request the full investment brief — machine specs, financials, and site selection for the Philippines market.
Request Investment Brief →This article is informational and is not medical advice. It does not replace diagnosis, treatment or follow-up by a treating physician. Regulatory clearance always applies to a specific device model and has an expiry date — ask to see the current certificate for the model offered to you.